Abeona Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Abeona Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 148% to $3,500,000. Profit margin reached -1548%. Total operating expenses were $48,502,000.
Profit Margin
| 2014 | 925K | -29.65M | -3205.73% |
|---|---|---|---|
| 2015 | 1.04M | -14.52M | -1396.73% |
| 2016 | 889K | -21.87M | -2460.4% |
| 2017 | 837K | -27.31M | -3263.92% |
| 2018 | 2.99M | -56.67M | -1890.29% |
| 2019 | 0 | -76.28M | |
| 2020 | 10M | -84.23M | -842.34% |
| 2021 | 3M | -84.93M | -2831.2% |
| 2022 | 1.41M | -39.69M | -2807.36% |
| 2023 | 3.5M | -54.18M | -1548.23% |
0H7R.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.5M | 1.41M | 3M | 10M | 0 | 2.99M | 837K | 889K | 1.04M | 925K |
Cost of revenue | 3.19M | 4.57M | 4.46M | 30.13M | 8.67M | 38.69M | 16.98M | 10.65M | 0 | 0 |
Gross profit | 302K | -3.16M | -1.46M | -20.13M | -8.67M | -35.7M | -16.15M | -9.76M | 1.04M | 925K |
Operating exp. | ||||||||||
Research and development | 31.09M | 28.96M | 34.32M | 30.13M | 48.56M | 39.89M | 16.98M | 11.33M | 4.71M | 342K |
Selling and marketing | 0 | -4.12M | -63K | -1.01M | -858K | 0 | 0 | 0 | 219K | 0 |
Total operating expenses | 48.50M | 42.09M | 55.90M | 52.90M | 68.41M | 22.46M | 27.93M | 14.11M | 18.66M | 27.16M |
Operating income | -48.2M | -45.25M | -57.37M | -48.50M | -77.09M | -58.16M | -27.83M | -23.88M | -18.17M | -3.13M |
Other income (expenses), net | -5.98M | 5.56M | -27.56M | -35.73M | 808K | 1.49M | 517K | 2.00M | 3.64M | -23.64M |
Income before tax | -54.18M | -39.69M | -84.93M | -84.23M | -76.28M | -56.67M | -27.31M | -21.87M | -14.52M | -26.77M |
Income tax expense | 0 | 3.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.87M |
Net income | -54.18M | -39.69M | -84.93M | -84.23M | -76.28M | -56.67M | -27.31M | -21.87M | -14.52M | -29.65M |
Earnings per share | ||||||||||
Basic EPS | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 | -29.81 | -16.4 | -16 | -13.16 | -381.56 |
Diluted EPS | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 | -29.81 | -16.4 | -16 | -13.16 | -381.56 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |